n-methylaspartate has been researched along with Brain Damage, Chronic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimori, T; Gao, Z; Hori, E; Ishii, Y; Ishizawa, S; Kawaguchi, M; Matsushima, T; Mori, H; Nabeshima, Y; Oya, T; Sabit, H; Sasahara, M; Sasaoka, T; Tokunaga, A; Zheng, L | 1 |
| Dehghani, F; Ghadban, C; Koch, M; Korf, HW; Kreutz, S | 1 |
| Acarin, L; Castellano, B; Faiz, M; González, B; Rohn, TT; Villapol, S | 1 |
| Jarrard, LE; Meldrum, BS | 1 |
| Ikonomidou, C; Turski, L | 1 |
| Johnston, MV; McDonald, JW; Shapiro, SM; Silverstein, FS | 1 |
| Hartmann, A; Mohr, JP | 1 |
| Bonvento, G; Lazzaro, A; Lipartiti, M; Mazzari, S; Zanoni, R | 1 |
1 review(s) available for n-methylaspartate and Brain Damage, Chronic
| Article | Year |
|---|---|
Neurodegenerative disorders: clues from glutamate and energy metabolism.
Topics: Aging; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brain Damage, Chronic; Brain Injuries; Brain Ischemia; Energy Metabolism; Excitatory Amino Acid Antagonists; Glutamates; Humans; N-Methylaspartate; Nerve Degeneration; Nervous System Diseases; Neurotoxins | 1996 |
7 other study(ies) available for n-methylaspartate and Brain Damage, Chronic
| Article | Year |
|---|---|
Mouse brains deficient in neuronal PDGF receptor-beta develop normally but are vulnerable to injury.
Topics: Animals; Blotting, Western; Brain; Brain Chemistry; Brain Damage, Chronic; DNA Primers; Freezing; Immunohistochemistry; In Situ Nick-End Labeling; Intermediate Filament Proteins; Mice; Mice, Knockout; Mutation; N-Methylaspartate; Nerve Tissue Proteins; Nestin; Neurons; Promoter Regions, Genetic; Receptor, Platelet-Derived Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction | 2006 |
Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures.
Topics: Animals; Animals, Newborn; Arachidonic Acids; Brain; Brain Damage, Chronic; Cannabinoids; Cell Count; Disease Models, Animal; Dronabinol; Endocannabinoids; Gliosis; Glycerides; Microglia; N-Methylaspartate; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Organ Culture Techniques; Plant Lectins; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Treatment Outcome | 2007 |
Caspase-3 activation in astrocytes following postnatal excitotoxic damage correlates with cytoskeletal remodeling but not with cell death or proliferation.
Topics: Animals; Animals, Newborn; Astrocytes; Brain; Brain Damage, Chronic; Caspase 3; Cell Death; Cell Proliferation; Cell Size; Cytoskeleton; Enzyme Activation; Female; Glial Fibrillary Acidic Protein; Gliosis; Intermediate Filaments; Male; N-Methylaspartate; Nerve Degeneration; Neurotoxins; Rats; Rats, Long-Evans; Vimentin | 2007 |
Selective excitotoxic pathology in the rat hippocampus.
Topics: Animals; Brain; Brain Damage, Chronic; Cell Death; Hippocampus; Ibotenic Acid; Kainic Acid; Male; N-Methylaspartate; Nerve Degeneration; Neurotoxins; Organ Specificity; Piperazines; Quisqualic Acid; Rats; Rats, Sprague-Dawley | 1993 |
Role of glutamate receptor-mediated excitotoxicity in bilirubin-induced brain injury in the Gunn rat model.
Topics: Animals; Apoptosis; Bilirubin; Brain Damage, Chronic; Disease Models, Animal; Dizocilpine Maleate; Drug Synergism; Excitatory Amino Acid Antagonists; Genotype; Glucuronosyltransferase; Injections; Kernicterus; N-Methylaspartate; Neurotoxins; Purkinje Cells; Rats; Rats, Gunn; Receptors, Glutamate; Sulfadimethoxine | 1998 |
Treatment of acute ischemic stroke: where are we?
Topics: Animals; Aspirin; Brain Damage, Chronic; Brain Ischemia; Calcium Channel Blockers; Cerebral Hemorrhage; Cerebrovascular Circulation; Clinical Trials as Topic; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; N-Methylaspartate; Neuroprotective Agents; Platelet Aggregation Inhibitors; Reperfusion Injury; Rodentia; Thrombolytic Therapy; Warfarin | 1999 |
Effects of monosialoganglioside GM1 in experimental models of ischemic brain damage.
Topics: Animals; Brain; Brain Damage, Chronic; Brain Ischemia; Choline O-Acetyltransferase; G(M1) Ganglioside; Injections, Intraventricular; N-Methylaspartate; Organ Size; Ouabain; Rats | 1991 |